Australian biotechs attract strong interest at US investor meeting

For the fifth year, AusBiotech has managed a presentation of Australian companies to San Francisco for an investor showcase held in conjunction with invitation-only the 30th JP Morgan Annual Healthcare Conference in the US.

The event held on the 9 January was again successful in attracting investors – this year 280, with a large contingent from China and Hong Kong – providing a valuable platform for Australian companies seeking investment and partnerships. Presenting companies included:

• Alchemia (ASX:ACL)
• Genetic Technologies (ASX:GTG)
• Phylogica (ASX:PYC)
• Sunshine Heart (ASX:SHC)
• Uptake Medical
• Viveve

AusBiotech has established a calendar of international and local investor showcase events. The next events on the international calendar are:

• Australian Life Science Showcase: Hong Kong 2012 - Wednesday 23 May 2012
• Australian Life Science Showcase: New York 2012 - Friday 15 June 2012 (just prior to BIO2012 convention in Boston)
• Australian Life Science Showcase: Edinburgh 2012 -Wednesday 3 October 2012
• Australian Life Science Showcase: London 2012 - Friday 5 October 2012

Upcoming local events include:

• ‘Brokers meet Biotech' Luncheon - Tuesday 28 February 2012, Melbourne, Victoria
• Medtech Investment Showcase - Monday 14 May 2012 (preceding AusMedtech annual conference), Sydney
• Australasian Life Sciences Investment Summit 2012 - Friday 2 November (part of the AusBiotech 2012 conference), Melbourne

For further information see www.ausbiotech.org/investment.